D
Danielle van Manen
Researcher at Janssen Pharmaceutica
Publications - 12
Citations - 1454
Danielle van Manen is an academic researcher from Janssen Pharmaceutica. The author has contributed to research in topics: Immunogenicity & Signal peptide. The author has an hindex of 8, co-authored 12 publications receiving 916 citations. Previous affiliations of Danielle van Manen include Crucell & Beth Israel Deaconess Medical Center.
Papers
More filters
Journal ArticleDOI
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques.
Noe B. Mercado,Roland Zahn,Frank Wegmann,Carolin Loos,Carolin Loos,Abishek Chandrashekar,Jingyou Yu,Jinyan Liu,Lauren Peter,Katherine McMahan,Lisa H. Tostanoski,Xuan He,David R. Martinez,Lucy Rutten,Rinke Bos,Danielle van Manen,Jort Vellinga,Jerome Custers,Johannes P. M. Langedijk,Ted Kwaks,Mark J. G. Bakkers,David Zuijdgeest,Sietske K. Rosendahl Huber,Caroline Atyeo,Caroline Atyeo,Stephanie Fischinger,Stephanie Fischinger,John S. Burke,Jared Feldman,Jared Feldman,Blake M. Hauser,Blake M. Hauser,Timothy M. Caradonna,Timothy M. Caradonna,Esther A. Bondzie,Gabriel Dagotto,Gabriel Dagotto,Makda S. Gebre,Makda S. Gebre,Emily Hoffman,Catherine Jacob-Dolan,Catherine Jacob-Dolan,Marinela Kirilova,Zhenfeng Li,Zijin Lin,Shant H. Mahrokhian,Lori F. Maxfield,Felix Nampanya,Ramya Nityanandam,Joseph P. Nkolola,Shivani A. Patel,John D. Ventura,Kaylee Verrington,Huahua Wan,Laurent Pessaint,Alex Van Ry,Kelvin Blade,Amanda Strasbaugh,Mehtap Cabus,Renita Brown,Anthony L. Cook,Serge Zouantchangadou,Elyse Teow,Hanne Andersen,Mark G. Lewis,Yongfei Cai,Bing Chen,Aaron G. Schmidt,Aaron G. Schmidt,R. Keith Reeves,Ralph S. Baric,Douglas A. Lauffenburger,Galit Alter,Paul Stoffels,Mathai Mammen,Johan Van Hoof,Hanneke Schuitemaker,Dan H. Barouch +77 more
TL;DR: Robust single-shot vaccine protection against SARS-CoV-2 in nonhuman primates is demonstrated and vaccine-elicited neutralizing antibody titers correlated with protective efficacy, suggesting an immune correlate of protection.
Journal ArticleDOI
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
Rinke Bos,Lucy Rutten,Joan E.M. van der Lubbe,Mark J. G. Bakkers,Gijs Hardenberg,Frank Wegmann,David Zuijdgeest,Adriaan H. de Wilde,Annemart Koornneef,Annemiek Verwilligen,Danielle van Manen,Ted Kwaks,Ronald Vogels,Tim J. Dalebout,Sebenzile K. Myeni,Marjolein Kikkert,Eric J. Snijder,Zhenfeng Li,Dan H. Barouch,Jort Vellinga,Johannes P. M. Langedijk,Roland Zahn,Jerome Custers,Hanneke Schuitemaker +23 more
TL;DR: In vitro characterization demonstrated that the introduction of stabilizing substitutions increased the ratio of neutralizing versus non-neutralizing antibody binding, suggestive for a prefusion conformation of the S protein, and the wild-type signal peptide was best suited for the correct cleavage needed for a natively folded protein.
Journal ArticleDOI
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch,Dan H. Barouch,Frank Tomaka,Frank Wegmann,Daniel J. Stieh,Galit Alter,Merlin L. Robb,Merlin L. Robb,Nelson L. Michael,Lauren Peter,Joseph P. Nkolola,Erica N. Borducchi,Abishek Chandrashekar,David Jetton,Kathryn E. Stephenson,Kathryn E. Stephenson,Wenjun Li,Bette T. Korber,Georgia D. Tomaras,David C. Montefiori,Glenda Gray,Nicole Frahm,M. Juliana McElrath,Lindsey R. Baden,Jennifer Johnson,Julia Hutter,Edith Swann,Etienne Karita,Hannah Kibuuka,Juliet Mpendo,Nigel Garrett,Kathy Mngadi,Kundai Chinyenze,Frances Priddy,Erica Lazarus,Fatima Laher,Sorachai Nitayapan,Punnee Pitisuttithum,Stephan Bart,Thomas B. Campbell,Robert Feldman,Gregg Lucksinger,Caroline Borremans,Katleen Callewaert,Raphaele Roten,Jerald C. Sadoff,Lorenz Scheppler,Mo Weijtens,Karin Feddes-de Boer,Danielle van Manen,Jessica Vreugdenhil,Roland Zahn,Ludo Lavreys,Steven Nijs,Jeroen Tolboom,Jenny Hendriks,Zelda Euler,Maria G. Pau,Hanneke Schuitemaker +58 more
TL;DR: All vaccine regimens demonstrated favourable safety and tolerability and immunogenicity and protective efficacy against a series of six repetitive, heterologous, intrarectal challenges with a rhesus peripheral blood mononuclear cell-derived challenge stock of simian-human immunodeficiency virus (SHIV-SF162P3).
Posted ContentDOI
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
Rinke Bos,Lucy Rutten,Joan E.M. van der Lubbe,Mark J. G. Bakkers,Gijs Hardenberg,Frank Wegmann,David Zuijdgeest,Adriaan H. de Wilde,Annemart Koornneef,Annemiek Verwilligen,Danielle van Manen,Ted Kwaks,Ronald Vogels,Tim J. Dalebout,Sebenzile K. Myeni,Marjolein Kikkert,Eric J. Snijder,Zhenfeng Li,Dan H. Barouch,Jort Vellinga,Johannes P. M. Langedijk,Roland Zahn,Jerome Custers,Hanneke Schuitemaker +23 more
TL;DR: In vitro characterization demonstrated that the introduction of stabilizing substitutions increased the ratio of neutralizing versus non-neutralizing antibody binding, suggestive for a prefusion conformation of the S protein, and the wild type signal peptide was best suited for the correct cleavage needed for a natively-folded protein.
Journal ArticleDOI
A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers
Lucy Rutten,Yen-Ting Lai,Sven Blokland,Daphné Truan,Ilona J. M. Bisschop,Nika Mindy Strokappe,Annemart Koornneef,Danielle van Manen,Gwo-Yu Chuang,S. Katie Farney,Hanneke Schuitemaker,Peter D. Kwong,Johannes P. M. Langedijk +12 more
TL;DR: This work reports a universal strategy that provides for correctly folded Env trimers of high quality and yield through a repair-and-stabilize approach, and provides a means to produce prefusion-closed EnV trimers from diverse HIV-1 strains, a substantial advance for vaccine development.